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This  study  was  designed  to  evaluate  whether  glycogen  synthase  kinase-3  (GSK-3)  inhibitor,  4-benzyl-
2-methyl-1,2,4-thiadiazolidine-3,5-dione  (TDZD-8)  induced  the  the  expression  of  connexin  43  (Cx43)
to  protect  against  renal  ischemia–reperfusion  (I/R)  injury  (RI/RI)  in  rats.  Rats  were  subjected  to 45  min
ischemia  followed  2 h  reperfusion  with  TDZD-8  (1 mg/kg)  for 5 min  prior  to reperfusion.  The  results  indi-
cated  that  TDZD-8  improved  the  recovery  of renal  function,  reduced  oxidative  stress  and  inﬂammationeywords:
SK-3
nhibitors (TDZD-8)
reconditioning
/R
enal ischemia reperfusion injury (RI/RI)
injury,  and  upregulated  the  expression  of  (Cx43)  as compared  to I/R group.  Therefore,  our study  demon-
strated  that  TDZD-8  provided  a  protection  to the  kidney  against  I/R injury  in rats  through  inducing the
expression  of (Cx43).
©  2015  The  Authors.  Published  by Elsevier  Ireland  Ltd.  This  is an open  access  article  under  the CC
BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/).x43
. Introduction
Ischemia–reperfusion (I/R)-induced injury is a primary reason
f acute organ dysfunction and that usually occurs in association
ith pathophysiological conditions, including primary surgery,
rauma, large area burns, and acute hypovolemia due to heavy ﬂuid
nd blood loss [1]. Although, reperfusion after ischemia generally
mproves the recovery of organ dysfunction caused by ischemia, in
ome instances, reperfusion may  aggravate the damage associated
ith ischemia [2,3].
Renal ischemia–reperfusion injury (RI/RI) is mediated by multi-
le pathophysiological mechanisms of which free radical damage
nd inﬂammatory factor are two key events [4,5]. During RI/RI,
ree radicals and inﬂammatory factor are both increased, result-
ng in extensive damage and apoptosis of tubular epithelial cells
6,7]. Among these factors, connexin 43 (Cx43) is involved in the
athophysiology of damage and apoptosis through multiple roles
8].Glycogen synthase kinase-3 (GSK-3) is a well-conserved,
biquitously expressed serine–threonine protein kinase originally
haracterized as one that phosphorylates glycogen synthase and
∗ Corresponding author at: Southwest University of Science and Technology, Col-
ege of Life Science and Engineering, Mianyang, Sichuan, 621010, PR China.
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K. Tong).
ttp://dx.doi.org/10.1016/j.toxrep.2015.10.005
214-7500/© 2015 The Authors. Published by Elsevier Ireland Ltd. This is an open access
c-nd/4.0/).regulates glucose metabolism [9]. Subsequently, studies demon-
strate that GSK-3 positively participated in a multitude of cellular
processes, including prolifeation, apoptosis–necrosis, plays an
important role in the pathophysiology of a number of diseases,
including kidney diseases. And more recent evidence suggest
that GSK3- plays dirty in acute kidney injury [10]. GSK-3
inhibitors strikingly prevent acute renal histological injury induced
by ischemia reperfusion [11–13]. Previous studies [14,15] have
showed that GSK-3 beta inhibitor (TDZD-8) reduces enteral and
hepatic ischemia–reperfusion injury through inhibiting the apo-
ptosis. And literature have showed that TDZD-8 can prevents
NSAID-induced acute kidney injury [11]. Cx43 is an important
material in cell connection communication, new research ﬁnd that
Cx43 plays an important role in drug preconditioning and ischemia
postconditioning [16]. In the current study, Cx43 may  be impor-
tant for exchanging small molecules in the glomerular apparatus
and tubular cells in the kidney, necessary for keeping a normal
renal function [17]. It has demonstrated that the glomerular of Cx43
expression can reduce RI/RI in rats [8].
Thus, TDZD-8 may  give play to protective effects against
ischemia–reperfusion injury in many organs, including the kidney.
Also, in different ischemia–reperfusion models, the role of Cx43
varied. However, to date, no studies have inspected the effects of
TDZD-8 on renal ischemia–reperfusion injury and Cx43 expres-
sion. Therefore, in this preliminary study, we inquire into possible
 article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-
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Fig. 1. Serum levels of BUN and Scr. The blood of sham, I/R, I/R + TDZD-8 groups rats
was collected 2 h after reperfusion and the serum levels of BUN and Scr measured.
Results expressed as mean ± SD. (A) A signiﬁcant increase from the sham group was392 Y. Wang, K. Tong / Toxicolo
rotective effects of TDZD-8 on renal ischemia–reperfusion injury
n rats. We  also inspect the expression of renal Cx43 in these rats.
. Materials and methods
.1. Animals and reagents
Sprague-Dawley (SD) rats (180–220 g) were supplied by the
nimal Research Center of Shantou University Medical College,
hantou, China. All the procedures and care administered to the
nimals had been approved by the institutional ethic committee.
ll reagents and drugs were purchased from Sigma.
.2. Animal experimental design
In the experiments 30 rats were randomly assigned to three
roups (each group had 10 rats): (1) sham + vehicle: 10% dimethyl
ulfoxide (DMSO, 1 ml/kg, i.v.) and subjected to the surgical pro-
edure; (2) I/R + vehicle: 45 min  of ischemia followed by 2 h
eperfusion with DMSO (1 ml/kg, i.v.); (3) I/R + TDZD-8:45 min  of
schemia followed by 2 h reperfusion with TDZD-8 (1 mg/kg, i.v.,
issolved in DMSO) for 5 min  prior to reperfusion. The doses were
elected based on previous reports [15,18].
.3. Surgical procedures of I/R
The methods had been described previously [4]. Rats were
nesthetized with 1% pentobarbital sodium (50 mg/kg) through
njecting in enterocoelia. The enterocoelia was opened and the
ilateral renal artery–vein were separated. The artery–vein were
ccluded for 45 min  by two artery clamps, and the success was
onﬁrmed by observing the color changing of kidney. The artery
lamp was removed 45 min  later and renal artery and vein were
llowed reperfusion for 2 h. The blood samples were collected via
bdominal aorta, and centrifuged at 3600 × g for 15 min  to harvest
he sera. The left kidneys of animals were immediately removed
nd stored at −20 ◦C for the analyses below, respectively.
.4. Measurement of serum BUN and Scr
The methods had been described previously [4]. Brieﬂy, the
lood of abdominal aorta was collected after reperfusion 2 h and
entrifuged at 3600 × g for 15 min  to harvest the sera. The BUN
nd Scr of serum were measured by O-phthalaldehyde–picric acid
ethod.
.5. Measurement of SOD activity–MDA content
The levels of SOD–MDA in tissues were measured to assess
ipid peroxidation as described previously [4]. The kidney was col-
ected after reperfusion 2 h and blood was washed from the tissue,
omogenized (100 mg)  in ice normal saline and made from 10%
omogenate, then centrifuged at 3600 × g for 15 min  to harvest the
upernatant. The SOD activity and MDA  content were measured
y xanthine oxidase–thiobarbituric acid method. The absorbance
as measured at 550–532 nm.  The level of lipid peroxides was
xpressed as U of SOD/mg prot and nmol of MDA/mg tissue.
.6. Measurement of IL-10 contentThe levels of IL-10 in tissues were measured to assess
nti-inﬂammatory as described previously [19]. The samping
rocess was the same as above and the IL-10 content was
easured by double antibody sandwich ELISA method. Thedenoted by (p < 0.01), a signiﬁcant decrease from the I/R group, by (p < 0.01); (B) a
signiﬁcant increase from the sham group was denoted by (p < 0.01), a signiﬁcant
decrease from the I/R group, by (p < 0.01).
absorbance was  measured at 450 nm.  The level of anti-
inﬂammatory was expressed as ng of IL-10/g tissue.
2.7. Western blot analysis
The methodology has been described previously [8]. Brieﬂy,
renal tissues were homogenized in protein lysate buffer. The
homogenates were resolved on polyacrylamide SDS gels, and
electrophoretically transferred to polyvinylidene diﬂuoride mem-
branes. The membranes were blocked with 3% BSA, incubated with
primary Abs against active Cx43 and subsequently, with alkaline
phosphatase conjugated secondary Abs. They were developed by
5-b-romo-4-chloro-3-indolyl phosphate–nitro blue tetrazolium.
Blots were stained with anti--actin Ab, and the levels of proteins
were normalized with respect to -actin band density.
2.8. Statistical analysis
All the data were expressed as mean values ± standard devia-
tion (SD). Statistical analysis between groups was carried out using
ANOVA with post-hoc testing. A value of less than 0.01 (P < 0.01)
was used for statistical signiﬁcance.
3. Results
3.1. Serum level of BUN and Scr
The serum levels of BUN and Scr I/R rats were signiﬁcantly
higher than that in Sham group (p < 0.01). The levels of BUN
ranged from 4.87 to 5.13 mmol  (4.97 ± 0.10 mmol) in Sham group,
whereas the level of BUN reached 25.89 ± 0.98 mmol in I/R group.
Administration of I/R + TDZD-8 signiﬁcantly, reduced the levels
of BUN (14.67 ± 0.58 mmol) compared with I/R group (p < 0.01)
(Fig. 1A); The levels of Scr ranged from 44.89 to 47.78 mol
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Fig. 2. The activity of SOD and the level of MDA  in renal tissues by I/R group induced.
The  renal tissues of sham, I/R, I/R + TDZD-8 groups rats were collected 2 h after reper-
fusion and the activity of SOD and the level of MDA  measured. Results expreed as
mean ± SD. (A) A signiﬁcant decrease from the sham group was denoted by (p < 0.01),
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Fig. 3. The level of IL-10 in renal tissues by I/R group induced. The renal tissues
of sham, I/R, I/R + TDZD-8 groups rats were collected 2 h after reperfusion and the
level of IL-10 measured. Results expreed as mean ± SD. A moderate increase from
the  sham group was  denoted by (p < 0.05), a signiﬁcant increase from the I/R group,
by (p < 0.01).
Fig. 4. The expression of Cx43 in renal tissues by I/R group induced. The renal tissues
of  sham, I/R, I/R + TDZD-8 groups rats were collected 2 h after reperfusion and the signiﬁcant increase from the I/R group, by (p < 0.01); (B) a signiﬁcant increase from
he  sham group was  denoted by (p < 0.01), a signiﬁcant decrease from the I/R group,
y  (p < 0.01).
46.13 ± 1.11 mol) in Sham group, whereas the level of Scr reached
38.32 ± 4.03 mol  in I/R group. Administration of I/R + TDZD-8 sig-
iﬁcantly reduced the levels of Scr (89.24 ± 3.03 mol) compared
ith I/R group (p < 0.01) (Fig. 1B).
.2. The activity of SOD and the level of MDA  in renal tissues
The activity of SOD in renal tissues which was induced by I/R was
igniﬁcantly less and than that in Sham group (p < 0.01). The activ-
ty of SOD in renal tissues reached 71.21 ± 1.00 U in Sham group,
hereas the activity of SOD in renal tissues reached 26.87 ± 0.82 U
y I/R group induced. Administration of I/R + TDZD-8 signiﬁcantly
ncreased the activity of SOD (46.67 ± 1.01 U) in renal tissues,
ompared with the activity of SOD in renal tissues by I/R group
nduced (p < 0.01) (Fig. 2A); The level of MDA  in renal tissues
hich was induced by I/R was signiﬁcantly higher than that in
ham group (p < 0.01). The level of MDA  in renal tissues reached
.66 ± 0.32 nmol in Sham group, whereas the level of MDA  in renal
issues reached 7.88 ± 0.27 nmol by I/R group induced. Administra-
ion of I/R + TDZD-8 reduced the level of MDA  (5.16 ± 0.14 nmol) in
enal tissues, compared with the level of MDA  in renal tissues by
/R group induced (p < 0.01) (Fig. 2B).
.3. The level of IL-10 in renal tissues
The level of IL-10 in renal tissues which was induced by I/R was
oderately higher than that in Sham group (p < 0.05). The level
f IL-10 in renal tissues reached 38.28 ± 1.44 ng in Sham group,
hereas the level of IL-10 in renal tissues reached 57.84 ± 0.76 ng
y I/R group induced. Administration of I/R + TDZD-8 signiﬁcantly
ncreased the level of IL-10 (82.07 ± 1.29 ng) in renal tissues, com-
ared with the level of IL-10 in renal tissues by I/R group induced
p < 0.01) (Fig. 3).expression of Cx43 measured. Results expreed as mean ± SD. A signiﬁcant decrease
from the sham group was denoted by (p < 0.01), a signiﬁcant increase from the I/R
group, by (p < 0.01).
3.4. The expression of Cx43 in renal tissues
The expression of Cx43 in renal tissues which was  induced by
I/R was signiﬁcantly less than that in Sham group (p < 0.01). Admin-
istration of I/R + TDZD-8 signiﬁcantly upregulated the expression of
Cx43 in renal tissues, compared with the expression of Cx43 in renal
tissues by I/R group induced (p < 0.01) (Fig. 4).
4. Discussion
RI/RI is a common clinical pathophysiologic phenomena. This
study examines the effect of GSK-3 inhibitor (TDZD-8, a selec-
tive GSK-3 inhibitor) on the expression of Cx43 exposed RI/RI in
rats. The results of the present study demonstrate that TDZD-8 has
protective effects on renal ischemia injury [13]. Glycogen synthase
kinase-3 (GSK-3) is a 47 kD serine–threonine kinase that is ﬁrst
observed to phosphorylate and inactivate glycogen synthase, a dis-
tal enzyme in the glycogen synthesis pathway [20]. GSK-3 is an
ideal “survival” enzyme, because it controls several extra metabolic
processes that are perturbed by ischemia, including cytoskeletal
dynamics, gene expression, proliferation, and apoptosis [21–29].
However, in acute models of injury, GSK-3 promotes the systemic
inﬂammatory response, increases the proinﬂammatory release of
cytokines, induces apoptosis, and alters cell proliferation [30,31].
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ubstantially, evidence indicates that GSK-3 inhibitor (TDZD-8)
reserves organ function after ischemia of the brain, gut [15,32].
urrent literature shows that TDZD-8 inhibits ischemia-induced
SK-3 kinase activity and Bax and caspase-3 activation, reduces
issue injury, and improves organ function is consistent with this
nterpretation [17].
Gap junction (GJ) is a special structure on the adjacent cell mem-
rane, it plays an important role in electricity and biochemical
ignals transmission between cells, and the function has a role in
he metabolism of cells, homeostasis, differentiation and prolifera-
ion. In addition, (GJ) is closely related to the pathological processes
f many diseases. (GJ) is a hollow cylinder water channel which is
ade up of special protein of adjacent cells-connexon, the channel
iameter is about 1.5–2.0 nm and its hole diameter size depends
n the types of connection protein(Cx), and it can permit the sub-
tances of molecular weight (<1KD) or small molecules (diameter
1.5 nm), such as cAMP, Ca2+, IP3, amino acids, the second messen-
er, hormones, drugs and carcinogens to cross, and large molecules
uch as proteins and RNA material cannot pass; (GJ) not only has
electivity to the molecularsize, but also selectivity to the charge
f molecules [33,34]. Current study indicates that intercellular gap
unction communication is operated by a family of connexins in
hich connexin 43 (Cx43) may  be critical for exchanging small
olecules in the glomerular apparatus and tubular cells in the kid-
ey, necessary for keeping a normal renal function. Decrements in
xpression of Cx43 imply impairs gap junctional communications
mong renal cells and play a role in abnormality of glomerular and
ubular cells contributing to pathologies of DN [17].
In this study, I/R reduces Cx43 expression, renal function (BUN,
cr), antioxidant ability (SOD, MDA), and anti-inﬂammatory abil-
ty (IL-10), these results shows that there is a certain relationship
etween Cx43 and ischemia–reperfusion injury. The result is con-
istent with early myocardial ischemia reperfusion injury [35,36].
DZD-8 can upregulate Cx43 expression and decrease renal injury.
hese hint that Cx43 is involved in TDZD-8 treatment in renal pro-
ection.
Previous study demonstrates that the activity of gene activa-
or in Cx43 is reduced after reperfusion, reﬂow and oxygen supply,
eutrophil inﬁltration, respiratory burst and release of inﬂamma-
ory mediators (such as TNF-, IL-10) [37–39]. In our study, Cx43
xpression is higher than I/R group and TDZD-8 increases the level
f IL-10, the result is consistent with literature.
To sum up, we ﬁnd that TDZD-8 improves renal function in rats
ollowing I/R, and up regulates the expression of renal Cx43. Further
tudies are needed to explore whether the renal protective roles
f TDZD-8 are due to this up regulated expression of Cx43 in the
idney.
eferences
[1] S.P. Zhou, W.T. Liao, L.K. Yang, L. Sun, Effects of sevoﬂurane pretreatment on
rnal Src and FAK expression in diabetic rats after renal ischemia–reperfusion
injury, Mol. Cell. Biochem. 384 (2013) 203–211.
[2] Mou  Hua, Protective effect of cyclooxygenase-2 inhibitor on the renal of
ischemia–reperfusion rats, Chin. J. Integr. Tradit. Western Nephrol. 12 (2011)
116–118 (article in Chinese).
[3] Gvozden Rosic, Ivan Srejovic, Vladimir Zivkovic, Dragica Selakovic, Jovana
Joksimovic, Vladimir Jakovljevic, The effects of N-acetylcysteine on
cisplatin-induced cardiotoxicity on isolated rat hearts after-term
globalischemia, Toxicol. Rep. 2 (2015) 996–1006.
[4] Rong Hao, Wang Yanling, Miao Zhihui, Wang Huijuan, Xia Xiaohong, Effect of
melatonin on myocardial oxygen free radical and cell apoptosis from renal
ischemia–reperfusion injury in rats, J. Ningxia Med. Univ. 33 (2011) 182
(article in Chinese).
[5] Y.Y. Chen, C.H. Yeh, E.C. So, D.P. Sun, L.Y. Wang, C.H. Hsing, Anticancer
drug2-methoxyestradiol protects against renal ischemia–reperfusion injury
by reducing inﬂammatory cytokines expression, Biomed. Res. Int. 431 (2014)
524.
[6] W.C. Chiang, C.T. Chien, S.L. Lin, Y.M. Chen, C.F. Lai, et al., Early activation of
bradykinin B2 receptor aggravates reactive oxygen species generation and
[
[ports 2 (2015) 1391–1395
renal damage inischemia–reperfusion injury, Free Radic. Biol. Med. 41 (2006)
1304–1314.
[7] Zhiming Li, Yumei Wang, Effect of NADPH oxidase inhibitor–apocynin on the
expression of Src homology-2 domain-containing phosphatase-1 (SHP-1)
exposed renal ischemia–reperfusion injury in rats, Toxicol. Rep. 2 (2015)
1111–1116.
[8] L.Z. Zhou, H. Sun, J.H. Jia, F. Ren, Effect of salvianolic acid B on connexin 43
expression in rat renal ischemic–reperfusion injury, China J. Mod. Med. 20
(2010) 4 (article in Chinese).
[9] G.V. Rayasam, V.K. Tulasi, R. Sodhi, J.A. Davis, A. Ray, Glycogen synthase
kinase 3: more than a name sake, Br. J. Pharmacol. 156 (2009) 885–898.
10] P.J. Nelson, L. Cantley, GSK3 plays dirty in acute kidney injury, J. Am.  Soc.
Nephrol. 21 (2010)
199–200.
11] H. Bao, Y. Ge, S. Zhuang, L.D. Dworkin, Z. Liu, R. Gong, Inhibition of glycogen
synthase kinase-3beta prevents NSAID-induced acute kidney injury, Kidney
Int.  81 (2012) 662–673.
12] C. Howard, S. Tao, H.-C. Yang, A.B. Fogo, J.R. Woodgett, R.C. Harris, et al.,
Speciﬁc deletion of glycogen synthase kinase-3beta in the renal proximal
tubule protects against acute nephrotoxic injury in mice, Kidney Int. 82
(2012) 1000–1009.
13] Z. Wang, A. Havasi, J. Gall, R. Bonegio, Z. Li, H. Mao, et al., GSK3 promotes
apoptosis after renal ischemic injury, J. Am. Soc. Nephrol. 21 (2010) 284–294.
14] Y. Takada, X. Fang, M.S. Jamaluddin, D.D. Boyd, B.B. Aqqarwal, Genetic
deletion of glycogen synthase kinase-3beta abrogates activation of Ikappa
Balpha kinase, JNK, Akt, and p44/p42 MAPK but potentiates apoptosis
induced by tumor necrosis factor, J. Biol. Chem. 279 (2004)
39541–39554.
15] S. Cuzzocrea, E. Mazzon, E. Esposito, C. Muia, M.  Abdelrahman, R. Di Paola,
et  al., Glycogen synthase kinase-3beta inhibiton attenuates the development
of ischaemia–reperfusion injury of the gut, Intensive Care Med. 33 (2007)
880–893.
16] K. Boengler, G. Dodoni, A. Rodriguez-Sinovas, A. Cabestrero, M. Rui-Meana,
GresP, et al., Connexin 43 in cardiomyocyte mitochondria and its increase by
ischemic preconditioning, Cardiovasc. Res. 67 (2005) 234–244.
17] C. Hu, X.D. Cong, D.Z. Dai, Y. Zhang, G.L. Zhang, Y. Dai, Argirein alleviates
diabetic nephropathy through attenuating NADPH oxidase, Cx43, and PERK in
renal tissue, Naunyn-Schmiedebergs Arch. Pharmacol. 383 (2011) 309–319.
18] H.K. Gao, Z. Yin, R.Q. Zhang, J. Zhang, F. Gao, H.C. Wang, GSK-3beta inhibitor
modulates TLR2/NF-kappa B signaling following myocardial
ischemia–reperfusion, Inﬂamm. Res. 58 (2009) 377–383.
19] M.  Yuan, B.Y. Shi, Y.Y. Qian, Effects of diosmin on changes of TNF-, IL-1, IL-6
IL-8 and IL-10 inserm and kidney tissues of rats with kidney
ischemia–reperfusion, Chin. J. Pathophysiol. 28 (2012) 10.
20] S. Frame, P. Cohen, GSK3 takes centre stage more than 20 yeas after its
discovery, Biochem. J. 359 (2001) 1–16.
21] W.J. Nelson, R. Nusse, Convergence of Wnt, beta-catenin–cadherin pathways,
Science 303 (2004) 1483–1487.
22] R.D. Loberg, E. Vesely, F.C. Brosius 3rd, Enhanced glycogen synthase
kinase-3beta activity mediates hypoxia-induced apoptosis of vascular smooth
muscle cells and is prevented by glucose transport and metabolism, J. Biol.
Chem. 277 (2002) 41667–41673.
23] D.M. Ferkey, D. Kimelman, GSK-3: new thoughts on an old enzyme, Dev. Biol.
225 (2000) 471–479.
24] C.A. Grimes, R.S. Jope, The multifaceted roles of glycogen synthase kinase
3beta in cellular signaling, Prog. Neurobiol. 65 (2001) 391–426.
25] R.S. Jope, G.V. Johnson, The glamour and gloom of glycogen synthase kinase-3,
Trends Biochem. Sci. 29 (2004) 95–102.
26] B.W. Doble, J.R. Woodgett, GSK-3: tricks of the trade for a multi-tasking
kinase, J. Cell. Sci. 116 (2003) 1175–1186.
27] R. Farooqui, S. Zhu, G. Fenteany, Glycogen synthase kinase-3 acts upstream of
ADP-ribosylation factor 6 and Rac1 to regulate epithelial cell migration, Exp.
Cell. Res. 312 (2006) 1514–1525.
28] J.F. Sanchez, L.F. Sniderhan, A.L. Williamson, S. Fan, S. Chakraborty-Sett, S.B.
Maggirwar, Glycogen synthase kinase 3beta-mediated apoptosis of primary
cortical astrocytes involves inhibition of nuclear factor kap-paB signaling,
Mol. Cell. Biol. 23 (2003) 4649–4662.
29] A. Novak, S.C. Hsu, C. Leung-Hagesteijn, G. Radeva, J. Papkoff, R. Monte-sano,
et  al., Cell adhesion and the integrin-linked kinase regulate the LEF-1 and
beta-catenin signaling pathways, Proc. Natl. Acad. Sci. U. S. A. 95 (1998)
4374–4379.
30] L. Dugo, M. Collin, D.A. Allen, N.S. Patel, I. Bauer, E.M. Mervaala, et al.,
GSK-3beta inhibitors attenuate the organ injury–dysfunction caused by
endotoxemia in the rat, Crit. Care Med. 33 (2005) 1903–1912.
31] S.H. Obligado, O. Ibraghimov-Beskrovnaya, A. Zuk, L. Meijer, P.J. Nelson,
CDK–GSK-3 inhibitors as therapeutic agents for parenchymal renal diseases,
Kidney Int. 73 (2008) 684–690.
32] M.  Collino, C. Thiemermann, R. Mastrocola, M.  Gallicchio, E. Benetti, G. Miglio,
et  al., Treatment with the glycogen synthase kinase-3beta inhibitor, TDZD-8,
affects transient cerebral ischemia–reperfusion injury in the rat
hippocampus, Shock 30 (2008) 299–307.33] J.C. Saez, J.E. Contreras, F.F. Bukauskas, M.A. Retamal, M.V. Bennett, Gap
junction in hemichannels in astrocytes of the CNS, Acta Physiol. Scand. 179
(2003) 9–22.
34] H.J. Jongsma, R. Wilders, Gap junctions in cardiovascular disease, Circ. Res. 86
(2000) 1193–1197.
gy Rep
[
[
[
[
(2014) 175–184.Y. Wang, K. Tong / Toxicolo
35] Y. Chen, H.Z. Hu, J.W. Wu,  Q.Y. Peng, G. Yang, Z.Q. Liao, Changes of connexin
43 in rabbit with early myocardial ischemia, Sichuan Da Xue Xue Bao Yi Xue
Ban 35 (2004) 191–193.
36] N. Zeevi-Levin, Y.D. Barac, Y. Reisner, I. Reiter, G. Yaniv, G. Meiry, et al., Gap
junctional remodeling by hypoxia in cultured neonatal rat ventricular
myoctytes, Cardiovasc. Res. 66 (2005) 64–73.
37] D. Garcia-Dorado, A. Rodriguez-Sinovas, M.  Ruiz-Meana, Gap
junction-mediated spread of cell injury and death during myocardial
ischemia–reperfusion, Cardivasc. Res. 61 (2004) 386–401.
[orts 2 (2015) 1391–1395 1395
38] L. Jellestad, T. Fink, S. Pradarutti, D. Kubulus, B. Wolf, I. Bauer, et al., Inhibition
of  glycogen synthase kinase (GSK)-3- improves liver microcirculation and
hepatocellular function after hemorrhagic shock, Eur. J. Pharmacol. 72439] L. Ma,  Y. Li, Y. Zhao, Q. Wang, Y. Nan, D. Mu,  et al., 3,5,4’-tri-O-acetyl
resveratrol ameliorates seawater exposure-induced lung injury by
upregulating connexin 43 expression in lung, Mediat. Inﬂamm. 2013 (2013)
182132, A:/B:/.
